Navigation Links
Stent Effective In Keeping Arteries Open

A new type of stent that releases medication appears safe and effective for preventing arteries from reclosing in coronary heart disease patients, // a process known as restenosis. The experimental stent, a mesh tube, releases the immunosuppressant drug everolimus. The drug acts by inhibiting cell reproduction and reducing cell growth in vessel walls. Unlike other similar drug-eluting stents, the one used in this study is made with a biodegradable polymer researchers believe will reduce and minimize long-term inflammation and restenosis.

This unique everolimus-coated stent freezes the biological process that leads to the renarrowing of arteries after catheter-based treatments. Not only are the patients free from symptoms, but they have open arteries 12 months after stent implantation. Results of the study show patients who received the everolimus-coated stents had 87-percent less narrowing in the treated portion of their arteries than those who received uncoated, or bare-metal, stents.

Of the 42 patients in the study, 27 received the new stents and 15 received standard stents. Standard stents have metal mesh tubes used to keep vessels open after balloon angioplasty opens the clogged artery. Everolimus also has promise in preventing heart and kidney rejection after transplantation.
'"/>




Page: 1

Related medicine news :

1. Stent shows promise in keeping arteries open
2. Failure of Drug-Coated Stent
3. Drug-Coated Stent
4. Stronger Backing for Drug-Coated Stents
5. Drug-Coated Stents – Proven to be More Effectiv
6. The Efficacy Of Newer Stents Questioned
7. Analyzing The Side Effects Of Sirolimus Stents
8. Stents That Release Medication To Check Artery Narrowing
9. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
10. Stenting: A Possible Remedy For Brain Artery Blockage
11. Drug-Eluting Stents Ensure Patency Of The Saphenous Vein Grafts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... two ostomy patients, standing as living proof that attitude and determination can combine ... and issues that spike around the holidays. This campaign will offer patients a ...
(Date:12/2/2016)... Hawaii (PRWEB) , ... December 02, 2016 , ... ... 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, offering ... in the field of pain management. , The demand for supplemental training ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 is ... create versatile lower third titles with just a few clicks of the mouse," said ... includes 30 lower third animations. Choose from various styles with accented animations, rigid boxes, ...
(Date:12/2/2016)... ... 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative teams ... Family Partnership and the Drug Enforcement Administration as part of the National Red Ribbon ... winning schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Columbia , December 2, 2016 bioLytical Laboratories, ... INSTI HIV-Selbsttest, bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... BEIJING , Dec. 2, 2016 ... ("Lianluo Smart" or "the Company") which develops, markets ... products in China and ... Cardiovascular Disease Diagnosis and Treatment New Progress Forum, ... Guangdong Province , Guangdong Provincial ...
(Date:12/2/2016)... Research and Markets has announced the addition of Jain ... and Companies" to their offering. ... , , Drug ... market value of drug delivery technologies and the anticancer drugs are ... to organs involved and the types of cancer as well as ...
Breaking Medicine Technology: